We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis—Reply

Elliot M. Frohman, MD, PhD1; Daniel Douek, MD, PhD2; Eugene O. Major, PhD2
[+] Author Affiliations
1Department of Neurology, University of Texas Southwestern Medical Center at Dallas
2National Institutes of Health, Bethesda, Maryland
JAMA Neurol. 2014;71(9):1192-1193. doi:10.1001/jamaneurol.2014.1858.
Text Size: A A A
Published online


In Reply In our article,1 we described the systematic, sensitive, and specific identification of JC virus, the etiologic agent responsible for the development of progressive multifocal leukoencephalopathy (PML), within circulating immune cells. Notwithstanding results in contradistinction to those we reported, Warnke et al appropriately acknowledged in their letter concerning our report that their study was confounded by an analysis of a significantly lower number of peripherally circulating immune cells. Their application of validated analysis techniques to compromised or inadequate samples ultimately culminated in their corresponding lack of ability to coelucidate the anticipated JCV and cytomegalovirus from the same tissues samples.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2014
Clemens Warnke, MD; Ortwin Adams, MD; Bernd Kieseier, MD
1Department of Neurology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
2Institute for Virology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
JAMA Neurol. 2014;71(9):1192. doi:10.1001/jamaneurol.2014.1855.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...